查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1836317

除颤器市场，按组件、按产品类型、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Defibrillator Market, By Component, By Product Type, By End user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 366 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年除颤器市场规模价值 83.4567 亿美元，2025 年至 2032 年的复合年增长率为 8.7%。

除颤器是一种医疗设备，旨在向心臟施加可控电击，以恢復正常心跳。它用于危及生命的情况，例如心室颤动或无脉性室性心动过速（心臟电活动变得混乱或停止有效泵血）。除颤器透过胸壁向心臟发送高能量脉衝，可以重置心律，使其有机会恢復正常收缩。这些设备可以是手动的，由训练有素的医疗专业人员使用，也可以是自动体外心臟去颤器（AED），供非专业人员在紧急情况下使用。

除颤器市场-市场动态

配备除颤器的救护车扩大紧急医疗服务，提高存活率

全球紧急医疗服务 (EMS) 的快速扩张在提高心臟骤停存活率方面发挥关键作用。无论城市还是农村地区，配备先进除颤技术的救护车的部署确保了患者在送往医院之前能够立即接受救治干预。心臟骤停的存活率高度依赖治疗速度，每分钟缺乏除颤都会大幅降低患者復原的机会。透过将除颤器整合到 EMS 车队中，急救人员可以在关键的「黄金时间」内启动治疗，从而改善患者的预后。许多国家正在大力投资升级其 EMS 基础设施。这不仅包括增加在役救护车数量，还包括确保每个单位都配备最先进的自动体外心臟去颤器 (AED) 或手动去颤器。这些设备对于难以获得医院服务的农村或偏远地区尤其重要。

此外，政府和卫生组织正在对急救医疗服务人员进行广泛的高级心臟生命支持 (ACLS) 方案培训，使他们能够有效操作除颤器并提高復苏成功率。智慧型除颤器与即时病患监护和无线资料传输的结合，进一步提升了急救医疗服务的能力。一些先进的型号可将患者心电图资料直接传输到医院急诊科，使医生能够在患者抵达后立即做好干预准备。这种连接确保了院前和院内护理之间的无缝交接，从而减少了治疗延误。因此，配备现代除颤系统的急救医疗服务不仅可以挽救生命，还可以降低心臟病患者长期併发症的风险。

例如，

2024年3月，英国国家医疗服务体系（NHS）推出了300辆配备先进手动去颤器和用户友好型自动体外心臟去颤器（AED）的新型救护车。这项大规模升级是加强院前心臟急救护理的更广泛计划的一部分。该计划特别着重于缩短心臟骤停时的干预时间，因为如果不立即进行除颤，心臟骤停患者的存活率会迅速下降。

除颤器市场-細項分析：

全球除颤器市场根据组件、产品类型、最终用户和地区进行细分。

根据组件类型，市场分为两类：植入式心臟復律去颤器 (ICD) 和体外去颤器 (ED)。植入式心臟復律去颤器凭藉其在持续心律监测和对高风险心臟病患者进行自动救生干预方面的有效性，占据市场主导地位。 ICD 广泛应用于有心室颤动、心室性心搏过速病史或有较高心臟骤停风险的患者。 ICD 无需外部干预即可在体内释放精确电击，使其成为心臟病专家和医疗保健提供者的首选。设备微型化、电池寿命延长以及远端监控的改进等技术进步，进一步增强了其在医院和专业心臟护理中心的应用。心血管疾病发生率的上升、人们对预防性心臟护理意识的提高以及一些国家优惠的报销政策也推动了对 ICD 的需求。随着 ICD 的持续创新和临床应用的不断扩展，预计 ICD 将在预测期内保持市场领先地位。

根据最终用户类型，市场分为四类：医院、公共市场、替代护理市场和家庭医疗保健。医院在市场中占据主导地位，主要原因是其在处理心臟骤停病例和其他心血管急诊方面发挥关键作用。医院配备了先进的基础设施、重症监护病房和技术娴熟的医疗保健专业人员，确保了除颤器的有效使用。大量的患者涌入和需要心臟监测的手术数量的增加进一步刺激了这一领域的需求。医院也采用最新的除颤技术，包括自动化和植入式设备，以改善病患的治疗效果。政府在医疗基础设施方面的措施和投资增强了其处理紧急情况的能力。此外，医院通常是紧急情况下的第一个治疗点，这使其成为可靠的最终用户群。随着全球心血管疾病病例持续上升，医院将继续成为除颤器应用的主要贡献者。

除颤器市场-地理洞察

在 2024 年的预测期内，亚太地区将占据全球除颤器市场的主导地位。

预计在 2024 年预测期内，亚太地区将在收入和市场成长方面主导全球除颤器市场。该地区的领导地位很大程度上得益于中国、印度、日本和韩国等国家心血管疾病盛行率的上升、医疗保健意识的提高以及医疗保健基础设施的快速扩张。这些国家的医院和专门的心臟护理中心越来越多地采用植入式心律转復除颤器 (ICD) 和先进的体外除颤器 (ED) 来治疗心臟骤停和其他危及生命的疾病。政府和私人医疗保健提供者在现代化紧急医疗服务方面的投资不断增加，包括部署配备除颤器的救护车，大大提高了心臟护理的可及性和及时性。此外，城市中心大规模的公共除颤计画以及人们对预防性心臟护理意识的提高正在推动市场扩张。微型设备、穿戴式除颤器和远端监控系统等技术进步进一步推动了医院、替代护理机构和家庭医疗保健机构的应用。

此外，亚太地区拥有庞大的患者群体、不断增长的可支配收入以及政府对心血管疾病管理的支持性倡议，这些因素共同构成了对除颤器製造商极具吸引力的市场。预计这些因素将在整个预测期内维持该地区在全球市场的主导地位。

预计在 2024 年的预测期内，北美的除颤器市场复合年增长率最高。

据估计，在 2024 年的预测期内，北美在全球除颤器市场中将实现最高的年复合成长率(CAGR)。这一强劲增长得益于该地区完善的医疗基础设施、对心臟护理的高度认识以及先进除颤技术的广泛采用。尤其是美国和加拿大，这两个国家对医院、紧急医疗服务和家庭医疗保健解决方案的投资正在增加，这加速了对植入式心律转復除颤器 (ICD) 和体外除颤器 (ED) 的需求。学校、机场、体育设施和工作场所的大规模公共除颤计画进一步支持了这一增长，缩短了对心臟骤停的反应时间。自动和穿戴式除颤器、更长的电池寿命和远端监控功能等技术进步也有助于提高医院、替代护理机构和家庭医疗保健使用者的采用率。此外，优惠的报销政策、心臟设备的保险覆盖以及政府加强院前急救的倡议，正在鼓励医疗服务提供者和消费者采用除颤解决方案。这些因素，加上心血管疾病盛行率的上升，使得北美在预测期内成为全球复合年增长率最快的市场。

除颤器市场-竞争格局：

全球除颤器市场竞争激烈，既有多家知名医疗器材製造商，也有专注于先进心臟护理解决方案的创新新创公司。各公司在技术创新、产品品质、地理分布和策略伙伴关係方面展开竞争。竞争格局的特点是产品发布、合作、合併和收购频繁，旨在加强市场地位和扩大区域影响力。主要参与者正在大力投资研发下一代除颤器，包括植入式心律转復除颤器 (ICD)、可穿戴式除颤器、半自动和自动体外去颤器 (AED)。这些创新专注于小型化、更长的电池寿命、增强的患者监护、与行动应用程式的连接以及即时心电图传输等功能。透过结合这些先进功能，製造商旨在提高用户友善性和临床疗效，从而在拥挤的市场中脱颖而出。从地理来看，由于心血管疾病盛行率上升、医疗支出成长以及政府大力推行院前心臟救治，各大公司正在亚太、拉丁美洲和中东等新兴市场拓展业务。与医院、急救医疗服务 (EMS) 提供者和公共医疗服务项目建立策略合作伙伴关係，进一步提升了市场渗透率。

此外，竞争环境鼓励定价策略、售后服务和培训计划，以维护客户忠诚度并确保除颤设备的正确使用。 FDA、CE 和其他地区机构的监管合规性和批准也在塑造竞争格​​局方面发挥关键作用。

目录

第 1 章：除颤器市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 除颤器市场片段（按组件）
    • 除颤器市场按产品类型细分
    • 除颤器市场片段（按最终用户）
    • 除颤器市场（按国家/地区）
    • 除颤器市场按地区细分
  • 竞争洞察

第三章：除颤器主要市场趋势

  • 除颤器市场驱动因素
    • 市场驱动因素的影响分析
  • 除颤器市场限制
    • 市场限制的影响分析
  • 除颤器市场机会
  • 除颤器市场未来趋势

第四章：除颤器产​​业研究

  • PESTEL分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：除颤器市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：除颤器市场格局

  • 2024年除颤器市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：除颤器市场-按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 植入式心臟復律去颤器（ICD）
    • 体外去颤器（ED）

第 8 章：除颤器市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 体外去颤器
    • 心臟復律去颤器
    • 手动 ED
    • 自动化 ED
    • 穿戴式心臟復律去颤器

第 9 章：除颤器市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 公共接取市场
    • 替代护理市场
    • 家庭医疗保健

第 10 章：除颤器市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美除颤器主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按组成部分）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲除颤器主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区（APAC）
    • 概述
    • 亚太地区除颤器主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（按组成部分）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲除颤器主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲除颤器主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（按组件）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：除颤器产​​业主要供应商分析

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Asahi Kasei Corporation
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Cardiac Science Corporation
    • CU Medical Systems, Inc.
    • Fukuda Denshi Co., Ltd.
    • Getinge Group
    • LivaNova PLC
    • Mediana Co. Ltd.
    • Medtronic plc
    • Metsis Medikal
    • MicroPort Scientific Corporation
    • Mindray Medical International
    • Nihon Kohden Corporation
    • Philips Healthcare
    • Progetti Srl
    • Schiller AG
    • Stryker Corporation
    • ZOLL Medical Corporation
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5645

Defibrillator Market size was valued at US$ 8,345.67 Million in 2024, expanding at a CAGR of 8.7% from 2025 to 2032.

A defibrillator is a medical device designed to deliver a controlled electric shock to the heart to restore a normal heartbeat. It is used in life-threatening situations such as ventricular fibrillation or pulseless ventricular tachycardia, where the heart's electrical activity becomes chaotic or stops effectively pumping blood. By sending a high-energy pulse through the chest wall to the heart, a defibrillator can reset the heart's rhythm, giving it a chance to resume normal contractions. These devices can be manual, used by trained medical professionals, or automated (AEDs), designed for use by laypersons in emergencies.

Defibrillator Market- Market Dynamics

Expansion of Emergency Medical Services with Defibrillator-Equipped Ambulances Improving Survival Rates

The rapid expansion of emergency medical services (EMS) globally is playing a pivotal role in improving cardiac arrest survival rates. In both urban and rural areas, the deployment of ambulances equipped with advanced defibrillation technology ensures immediate life-saving intervention before the patient reaches a hospital. Cardiac arrest survival rates are highly dependent on the speed of treatment every minute without defibrillation significantly reduces the chances of recovery. By integrating defibrillators into EMS fleets, emergency responders can initiate treatment within the critical "golden minutes," improving patient outcomes. Many countries are investing heavily in upgrading their EMS infrastructure. This includes not only expanding the number of ambulances in service but also ensuring each unit carries state-of-the-art automated external defibrillators (AEDs) or manual defibrillators. These devices are particularly crucial for rural or remote regions where hospital access is delayed.

Moreover, governments and health organizations are training EMS personnel extensively in advanced cardiac life support (ACLS) protocols, enabling them to operate defibrillators effectively and increase the success rate of resuscitation efforts. The integration of smart defibrillators with real-time patient monitoring and wireless data transfer is further enhancing EMS capabilities. Some advanced models transmit patient ECG data directly to hospital emergency departments, allowing doctors to prepare for immediate intervention upon arrival. This connectivity ensures a seamless handover between pre-hospital and in-hospital care, reducing treatment delays. As a result, EMS equipped with modern defibrillation systems is not only saving lives but also reducing the risk of long-term complications in cardiac patients.

For Instance,

In March 2024, The National Health Service (NHS) rolled out 300 newly built ambulances equipped with both advanced manual defibrillators and user-friendly automated external defibrillators (AEDs). This large-scale upgrade is part of a broader initiative to strengthen pre-hospital cardiac emergency care. The program specifically focuses on improving intervention times during sudden cardiac arrests, where survival rates drop rapidly without immediate defibrillation.

Defibrillator Market- Key Insights

As per the analysis shared by our research analyst, the global Defibrillator market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2025-2032).

Based on component segmentation, Implantable Cardioverter Defibrillators (ICDs) accounted for the largest market share in 2024.

Based on product type segmentation, S-ICD was the leading product type in 2024.

Based on end-user segmentation, Hospitals were the dominant end-user category in 2024.

Based on region, Asia Pacific was the leading revenue generator in 2024.

Defibrillator Market- Segmentation Analysis:

The Global Defibrillator Market is segmented based on by component, by product type, by end user and region.

The market is divided into two categories based on component type: implantable cardioverter defibrillators (ICDs), external defibrillators (ED). The implantable cardioverter defibrillators dominate the market driven by their effectiveness in continuous heart rhythm monitoring and automatic life-saving intervention for high-risk cardiac patients. ICDs are widely adopted in patients with a history of ventricular fibrillation, ventricular tachycardia, or those at significant risk of sudden cardiac arrest. Their capability to deliver precise electrical shocks inside the body without external intervention makes them a preferred choice among cardiologists and healthcare providers. Technological advancements, such as miniaturized devices, longer battery life, and improved remote monitoring, have further strengthened their adoption across hospitals and specialized cardiac care centers. The demand for ICDs is also supported by rising incidences of cardiovascular diseases, increasing awareness about preventive cardiac care, and favorable reimbursement policies in several countries. With ongoing innovations and expanding clinical applications, ICDs are expected to maintain their market leadership over the forecast period.

The market is divided into four categories based on end user type: hospital, public access market, alternate care market, home healthcare. The hospitals dominate the market primarily driven by its critical role in managing sudden cardiac arrest cases and other cardiovascular emergencies. Hospitals are equipped with advanced infrastructure, intensive care units, and skilled healthcare professionals, which ensures the effective use of defibrillators. A large patient inflow and the rising number of surgeries requiring cardiac monitoring further boost demand in this segment. Hospitals also adopt the latest defibrillation technologies, including automated and implantable devices, to improve patient outcomes. Government initiatives and investments in healthcare infrastructure strengthen their capacity to manage emergencies. Moreover, hospitals are often the first point of treatment during emergencies, making them a reliable end-user segment. As cardiovascular disease cases continue to rise globally, hospitals will remain the leading contributor to defibrillator adoption.

Defibrillator Market- Geographical Insights

Asia Pacific dominates the global defibrillator market during the forecast period in 2024.

Asia Pacific is projected to dominate the global defibrillator market during the forecast period in 2024, both in terms of revenue and market growth. The region's leadership is largely driven by the increasing prevalence of cardiovascular diseases, rising healthcare awareness, and the rapid expansion of healthcare infrastructure in countries such as China, India, Japan, and South Korea. Hospitals and specialized cardiac care centers in these countries are increasingly adopting Implantable Cardioverter Defibrillators (ICDs) and advanced External Defibrillators (EDs) to manage sudden cardiac arrest and other life-threatening conditions. The growing investments by governments and private healthcare providers in modernizing emergency medical services, including the deployment of defibrillator-equipped ambulances, have significantly enhanced accessibility and timely cardiac care. Additionally, large-scale public access defibrillation programs in urban centres, along with rising awareness of preventive cardiac care, are fuelling market expansion. Technological advancements such as miniaturized devices, wearable defibrillators, and remote monitoring systems are further driving adoption across hospitals, alternate care facilities, and home healthcare setups.

Moreover, the region benefits from a large patient pool, increasing disposable income, and supportive government initiatives for cardiovascular disease management, which collectively make Asia Pacific a highly attractive market for defibrillator manufacturers. These factors are expected to sustain the region's dominance in the global market throughout the forecast period.

North America is estimated to register the highest CAGR in the defibrillator market during the forecast period in 2024.

North America is estimated to register the highest compound annual growth rate (CAGR) in the global Defibrillator Market during the forecast period in 2024. This robust growth is driven by the region's well-established healthcare infrastructure, high awareness of cardiac care, and the widespread adoption of advanced defibrillation technologies. The United States and Canada, in particular, are witnessing increasing investments in hospitals, emergency medical services, and home healthcare solutions, which are accelerating the demand for both Implantable Cardioverter Defibrillators (ICDs) and External Defibrillators (EDs). The growth is further supported by large-scale public access defibrillation programs in schools, airports, sports facilities, and workplaces, improving response times for sudden cardiac arrests. Technological advancements such as automated and wearable defibrillators, enhanced battery life, and remote monitoring capabilities are also contributing to higher adoption rates among hospitals, alternate care facilities, and home healthcare users. Additionally, favorable reimbursement policies, insurance coverage for cardiac devices, and government initiatives to enhance pre-hospital emergency care are encouraging both healthcare providers and consumers to adopt defibrillation solutions. The combination of these factors, along with rising cardiovascular disease prevalence, positions North America as the fastest-growing market globally in terms of CAGR during the forecast period.

Defibrillator Market- Competitive Landscape:

The global defibrillator market is highly competitive, characterized by the presence of several established medical device manufacturers and innovative startups focused on advanced cardiac care solutions. Companies are competing based on technological innovation, product quality, geographical presence, and strategic partnerships. The competitive landscape is marked by frequent product launches, collaborations, mergers, and acquisitions aimed at strengthening market position and expanding regional reach. Key players are investing significantly in research and development to introduce next-generation defibrillators, including implantable cardioverter defibrillators (ICDs), wearable defibrillators, semi-automatic and automated external defibrillators (AEDs). These innovations focus on features such as miniaturization, longer battery life, enhanced patient monitoring, connectivity with mobile apps, and real-time ECG transmission. By incorporating these advanced features, manufacturers aim to improve user-friendliness and clinical efficacy, thereby differentiating their offerings in a crowded market. Geographically, companies are expanding operations in emerging markets such as Asia Pacific, Latin America, and the Middle East due to rising cardiovascular disease prevalence, growing healthcare expenditure, and government initiatives for pre-hospital cardiac care. Strategic partnerships with hospitals, EMS providers, and public access programs further help in increasing market penetration.

Additionally, the competitive environment encourages pricing strategies, after-sales services, and training programs to maintain customer loyalty and ensure the proper use of defibrillation devices. Regulatory compliance and approvals from agencies such as the FDA, CE, and other regional authorities also play a critical role in shaping the competitive landscape.

Recent Developments:

In January 2025, The Australian government committed AUD 50 million to upgrading its national ambulance fleet with portable defibrillators and advanced patient monitoring devices. These portable systems allow EMS personnel to initiate life-saving measures in route to hospitals, even in remote regions. The initiative is expected to significantly improve survival rates for out-of-hospital cardiac arrest cases, which account for thousands of preventable deaths annually.

In June 2024, Stryker launched the LIFEPAK 35 monitor/defibrillator, featuring advanced proprietary tools built on an intuitive, modern platform. The device is designed to provide healthcare professionals with rapid, accurate patient data during cardiac emergencies. Its integrated features, including real-time ECG monitoring and improved defibrillation algorithms, enhance the chances of successful resuscitation. The launch strengthens Stryker's portfolio in both hospital and pre-hospital emergency care markets.

In October 2024, MicroPort CRM received approval from China's National Medical Products Administration (NMPA) for the PLATINIUM implantable cardioverter defibrillator (ICD). This marks the first ICD manufactured domestically in China to gain regulatory clearance. The device provides continuous monitoring and automated shock delivery for patients at risk of sudden cardiac arrest. Its approval is expected to expand access to advanced cardiac care across hospitals and specialty clinics in China.

In October 2024, ZOLL announced that its AED Plus defibrillator received approval under the European Union Medical Device Regulation (EU MDR). This certification ensures full compliance with stringent European safety and performance standards, enabling wider distribution across EU countries. The AED Plus is designed for ease of use, rapid deployment, and improved survival outcomes in cardiac emergencies. By meeting EU MDR standards, ZOLL enhances its credibility and competitiveness in the European defibrillator market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEFIBRILLATOR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Asahi Kasei Corporation
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • CU Medical Systems, Inc.
  • Fukuda Denshi Co., Ltd.
  • Getinge Group
  • LivaNova PLC
  • Mediana Co. Ltd.
  • Medtronic plc
  • Metsis Medikal
  • MicroPort Scientific Corporation
  • Mindray Medical International
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Progetti Srl
  • Schiller AG
  • Stryker Corporation
  • ZOLL Medical Corporation
  • Others

GLOBAL DEFIBRILLATOR MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Implantable Cardioverter Defibrillators (ICDs)
  • External Defibrillators (ED)Front
  • Others

GLOBAL DEFIBRILLATOR MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • S-ICD
  • T-ICD
  • Manual ED
  • Automated ED
  • Wearable Cardioverter Defibrillators

GLOBAL DEFIBRILLATOR MARKET, BY END USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare

GLOBAL DEFIBRILLATOR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Defibrillator Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Defibrillator Market Snippet by Component
    • 2.1.2. Defibrillator Market Snippet by Product Type
    • 2.1.3. Defibrillator Market Snippet by End User
    • 2.1.4. Defibrillator Market Snippet by Country
    • 2.1.5. Defibrillator Market Snippet by Region
  • 2.2. Competitive Insights

3. Defibrillator Key Market Trends

  • 3.1. Defibrillator Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Defibrillator Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Defibrillator Market Opportunities
  • 3.4. Defibrillator Market Future Trends

4. Defibrillator Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Defibrillator Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Defibrillator Market Landscape

  • 6.1. Defibrillator Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Defibrillator Market- By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Implantable Cardioverter Defibrillators (ICDs)
    • 7.1.3. External Defibrillators (ED)

8. Defibrillator Market- By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. S-ICD
    • 8.1.3. T-ICD
    • 8.1.4. Manual ED
    • 8.1.5. Automated ED
    • 8.1.6. Wearable Cardioverter Defibrillators

9. Defibrillator Market- By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Public Access Market
    • 9.1.4. Alternate Care Market
    • 9.1.5. Home Healthcare

10. Defibrillator Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Defibrillator Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Defibrillator Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Defibrillator Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Defibrillator Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Defibrillator Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Defibrillator Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Asahi Kasei Corporation
    • 11.2.3. BIOTRONIK SE & Co. KG
    • 11.2.4. Boston Scientific Corporation
    • 11.2.5. Cardiac Science Corporation
    • 11.2.6. CU Medical Systems, Inc.
    • 11.2.7. Fukuda Denshi Co., Ltd.
    • 11.2.8. Getinge Group
    • 11.2.9. LivaNova PLC
    • 11.2.10. Mediana Co. Ltd.
    • 11.2.11. Medtronic plc
    • 11.2.12. Metsis Medikal
    • 11.2.13. MicroPort Scientific Corporation
    • 11.2.14. Mindray Medical International
    • 11.2.15. Nihon Kohden Corporation
    • 11.2.16. Philips Healthcare
    • 11.2.17. Progetti Srl
    • 11.2.18. Schiller AG
    • 11.2.19. Stryker Corporation
    • 11.2.20. ZOLL Medical Corporation
    • 11.2.21. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us